Form 483

TAIWAN BIOTECH CO., LTD. Form 483, 2017-09-11

FDA issued a Form 483 to TAIWAN BIOTECH CO., LTD. on 2017-09-11 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

TAIWAN BIOTECH CO., LTD. · Taoyuan City, Taiwan · Issued September 11, 2017

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

11 Sep 2017
21 CFR 211.180(e)

Records reviewed annually

Cited by Ileana Barreto-Pettit

11 Sep 2017
21 CFR 211.180(e)(1)

Representative Number of Batches for Annual Review

Cited by Ileana Barreto-Pettit

11 Sep 2017
21 CFR 211.166(a)

Written program not followed

Cited by Ileana Barreto-Pettit

11 Sep 2017
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Ileana Barreto-Pettit

Inspected site

TBTAIWAN BIOTECH CO., LTD.Taoyuan City, Taiwan

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere